Laboratory-based data for all GIT molecular panels requested for patients at PathCare laboratories for the period June to September 2026 are presented in this report. Trends noted with regard to common bacterial, viral and parasitic diarrhoeal pathogens are...
Knowledge Hub
Respiratory Pathogen Statistics October 2026
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during October 2026 (epidemiological weeks 41-44). The data is dependent on submission of samples by clinicians and therefore may not be...
Discontinuation of the Urine Bilharzia CCA Antigen Test
PathCare would like to inform you that, with immediate effect, the Bilharzia Urine CCA (circulating cathodic antigen) test will no longer be performed at our diagnostic laboratories. Our supplier has advised that the test kits cannot currently be produced, owing to...
Respiratory Pathogen Statistics August 2026
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during August 2026 (epidemiological weeks 32-35). The data is dependent on submission of samples by clinicians and therefore may not be...
Vitamin A & E testing now In-house
We are proud to announce that, from 1 September 2026, PathCare will perform Vitamin A (retinol) and Vitamin E (a-tocopherol) testing using HPLC-UV. Bringing these tests in-house will improve turnaround times and introduce updated reference intervals aligned with...
CKD Assessment Beyond Creatinine: The role of Cystatin C in the KDIGO CKD 2024 pathway
What is Cystatin C, and why is it useful? Cystatin C is a low-molecular-weight protein produced at a relatively constant rate by all nucleated cells. It is freely filtered by the glomeruli and then metabolised in the proximal tubules. Unlike creatinine, it is much...
Blood Cancers Awareness Month
This Cancer Awareness Month, we highlight how one of the simplest and most affordable tests in medicine - the full blood count (FBC)- is often the very first clue to a haematological malignancy. A single abnormal result, read alongside the clinical picture, can open...
Respiratory Pathogen Statistics July 2026
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during July 2026 (epidemiological weeks 23-26). The data is dependent on submission of samples by clinicians and therefore may not be...
Optimizing TB Diagnostics: Prioritizing Molecular Testing & Culture
We would like to highlight an update in the diagnostic approach to tuberculosis (TB) investigation. While smear microscopy for acid fast bailli (AFB) has long been used for Mycobacterium tuberculosis complex (MTB) detection, it is no longer recommended as the initial...
PMOS: The new name for PCOS and what it means for laboratory assessments
Why the name change? The term PCOS is increasingly recognised as misleading because pathological ovarian cysts are not a defining feature. PMOS better reflects the multisystem endocrine and metabolic nature of the disorderPMOS
- Knowledge Hub (174)
- Allergy (1)
- Antimicrobials & infection (5)
- Autoimmune (1)
- Chemical Pathology (15)
- Endocrinology (1)
- Epidemiology (3)
- Gastrointestinal (2)
- Genetics (6)
- Genitourinary (2)
- Haematology (9)
- HIV/TB (3)
- Infectious Diseases (10)
- Neurology (4)
- Obstetric and Neonatal care (4)
- Oncology (1)
- Ophthalmology (1)
- Respiratory (2)
- Serology (3)
- Virology (44)
- Latest News (1)
- Microbiology (29)
- Molecular Pathology (17)
- Uncategorized (2,759)
- Wheelchair friendly (16)